A Smart Shoe Insole to Monitor Frail Older Adults’ Walking Speed: Results of Two Evaluation Phases Completed in a Living Lab and Through a 12-Week Pilot Study
BackgroundRecent World Health Organization reports propose wearable devices to collect information on activity and walking speed as innovative health indicators. However, mainstream consumer-grade tracking devices and smartphone apps are often inaccurate and require long-term...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2021-07-01
|
Series: | JMIR mHealth and uHealth |
Online Access: | https://mhealth.jmir.org/2021/7/e15641 |
_version_ | 1797735888098164736 |
---|---|
author | Antoine Piau Zara Steinmeyer Yoann Charlon Laetitia Courbet Vincent Rialle Benoit Lepage Eric Campo Fati Nourhashemi |
author_facet | Antoine Piau Zara Steinmeyer Yoann Charlon Laetitia Courbet Vincent Rialle Benoit Lepage Eric Campo Fati Nourhashemi |
author_sort | Antoine Piau |
collection | DOAJ |
description |
BackgroundRecent World Health Organization reports propose wearable devices to collect information on activity and walking speed as innovative health indicators. However, mainstream consumer-grade tracking devices and smartphone apps are often inaccurate and require long-term acceptability assessment.
ObjectiveOur aim is to assess the user acceptability of an instrumented shoe insole in frail older adults. This device monitors participants’ walking speed and differentiates active walking from shuffling after step length calibration.
MethodsA multiphase evaluation has been designed: 9 older adults were evaluated in a living lab for a day, 3 older adults were evaluated at home for a month, and a prospective randomized trial included 35 older adults at home for 3 months. A qualitative research design using face-to-face and phone semistructured interviews was performed. Our hypothesis was that this shoe insole was acceptable in monitoring long-term outdoor and indoor walking. The primary outcome was participants' acceptability, measured by a qualitative questionnaire and average time of insole wearing per day. The secondary outcome described physical frailty evolution in both groups.
ResultsLiving lab results confirmed the importance of a multiphase design study with participant involvement. Participants proposed insole modifications. Overall acceptability had mixed results: low scores for reliability (2.1 out of 6) and high scores for usability (4.3 out of 6) outcomes. The calibration phase raised no particular concern. During the field test, a majority of participants (mean age 79 years) were very (10/16) or quite satisfied (3/16) with the insole's comfort at the end of the follow-up. Participant insole acceptability evolved as follows: 63% (12/19) at 1 month, 50% (9/18) at 2 months, and 75% (12/16) at 3 months. A total of 9 participants in the intervention group discontinued the intervention because of technical issues. All participants equipped for more than a week reported wearing the insole every day at 1 month, 83% (15/18) at 2 months, and 94% (15/16) at 3 months for 5.8, 6.3, and 5.1 hours per day, respectively. Insole data confirmed that participants effectively wore the insole without significant decline during follow-up for an average of 13.5 days per 4 months and 5.6 hours per day. For secondary end points, the change in frailty parameters or quality of life did not differ for those randomly assigned to the intervention group compared to usual care.
ConclusionsOur study reports acceptability data on an instrumented insole in indoor and outdoor walking with remote monitoring in frail older adults under real-life conditions. To date, there is limited data in this population set. This thin instrumentation, including a flexible battery, was a technical challenge and seems to provide an acceptable solution over time that is valued by participants. However, users still raised certain acceptability issues. Given the growing interest in wearable health care devices, these results will be useful for future developments.
Trial RegistrationClinicalTrials.gov NCT02316600; https://clinicaltrials.gov/ct2/show/NCT02316600 |
first_indexed | 2024-03-12T13:05:34Z |
format | Article |
id | doaj.art-94c860b410764d469d47151b86b772ec |
institution | Directory Open Access Journal |
issn | 2291-5222 |
language | English |
last_indexed | 2024-03-12T13:05:34Z |
publishDate | 2021-07-01 |
publisher | JMIR Publications |
record_format | Article |
series | JMIR mHealth and uHealth |
spelling | doaj.art-94c860b410764d469d47151b86b772ec2023-08-28T16:59:45ZengJMIR PublicationsJMIR mHealth and uHealth2291-52222021-07-0197e1564110.2196/15641A Smart Shoe Insole to Monitor Frail Older Adults’ Walking Speed: Results of Two Evaluation Phases Completed in a Living Lab and Through a 12-Week Pilot StudyAntoine Piauhttps://orcid.org/0000-0003-2849-3057Zara Steinmeyerhttps://orcid.org/0000-0002-6169-3395Yoann Charlonhttps://orcid.org/0000-0003-0934-6588Laetitia Courbethttps://orcid.org/0000-0002-0024-529XVincent Riallehttps://orcid.org/0000-0002-0179-3837Benoit Lepagehttps://orcid.org/0000-0002-1586-2055Eric Campohttps://orcid.org/0000-0001-7647-8498Fati Nourhashemihttps://orcid.org/0000-0003-4029-9433 BackgroundRecent World Health Organization reports propose wearable devices to collect information on activity and walking speed as innovative health indicators. However, mainstream consumer-grade tracking devices and smartphone apps are often inaccurate and require long-term acceptability assessment. ObjectiveOur aim is to assess the user acceptability of an instrumented shoe insole in frail older adults. This device monitors participants’ walking speed and differentiates active walking from shuffling after step length calibration. MethodsA multiphase evaluation has been designed: 9 older adults were evaluated in a living lab for a day, 3 older adults were evaluated at home for a month, and a prospective randomized trial included 35 older adults at home for 3 months. A qualitative research design using face-to-face and phone semistructured interviews was performed. Our hypothesis was that this shoe insole was acceptable in monitoring long-term outdoor and indoor walking. The primary outcome was participants' acceptability, measured by a qualitative questionnaire and average time of insole wearing per day. The secondary outcome described physical frailty evolution in both groups. ResultsLiving lab results confirmed the importance of a multiphase design study with participant involvement. Participants proposed insole modifications. Overall acceptability had mixed results: low scores for reliability (2.1 out of 6) and high scores for usability (4.3 out of 6) outcomes. The calibration phase raised no particular concern. During the field test, a majority of participants (mean age 79 years) were very (10/16) or quite satisfied (3/16) with the insole's comfort at the end of the follow-up. Participant insole acceptability evolved as follows: 63% (12/19) at 1 month, 50% (9/18) at 2 months, and 75% (12/16) at 3 months. A total of 9 participants in the intervention group discontinued the intervention because of technical issues. All participants equipped for more than a week reported wearing the insole every day at 1 month, 83% (15/18) at 2 months, and 94% (15/16) at 3 months for 5.8, 6.3, and 5.1 hours per day, respectively. Insole data confirmed that participants effectively wore the insole without significant decline during follow-up for an average of 13.5 days per 4 months and 5.6 hours per day. For secondary end points, the change in frailty parameters or quality of life did not differ for those randomly assigned to the intervention group compared to usual care. ConclusionsOur study reports acceptability data on an instrumented insole in indoor and outdoor walking with remote monitoring in frail older adults under real-life conditions. To date, there is limited data in this population set. This thin instrumentation, including a flexible battery, was a technical challenge and seems to provide an acceptable solution over time that is valued by participants. However, users still raised certain acceptability issues. Given the growing interest in wearable health care devices, these results will be useful for future developments. Trial RegistrationClinicalTrials.gov NCT02316600; https://clinicaltrials.gov/ct2/show/NCT02316600https://mhealth.jmir.org/2021/7/e15641 |
spellingShingle | Antoine Piau Zara Steinmeyer Yoann Charlon Laetitia Courbet Vincent Rialle Benoit Lepage Eric Campo Fati Nourhashemi A Smart Shoe Insole to Monitor Frail Older Adults’ Walking Speed: Results of Two Evaluation Phases Completed in a Living Lab and Through a 12-Week Pilot Study JMIR mHealth and uHealth |
title | A Smart Shoe Insole to Monitor Frail Older Adults’ Walking Speed: Results of Two Evaluation Phases Completed in a Living Lab and Through a 12-Week Pilot Study |
title_full | A Smart Shoe Insole to Monitor Frail Older Adults’ Walking Speed: Results of Two Evaluation Phases Completed in a Living Lab and Through a 12-Week Pilot Study |
title_fullStr | A Smart Shoe Insole to Monitor Frail Older Adults’ Walking Speed: Results of Two Evaluation Phases Completed in a Living Lab and Through a 12-Week Pilot Study |
title_full_unstemmed | A Smart Shoe Insole to Monitor Frail Older Adults’ Walking Speed: Results of Two Evaluation Phases Completed in a Living Lab and Through a 12-Week Pilot Study |
title_short | A Smart Shoe Insole to Monitor Frail Older Adults’ Walking Speed: Results of Two Evaluation Phases Completed in a Living Lab and Through a 12-Week Pilot Study |
title_sort | smart shoe insole to monitor frail older adults walking speed results of two evaluation phases completed in a living lab and through a 12 week pilot study |
url | https://mhealth.jmir.org/2021/7/e15641 |
work_keys_str_mv | AT antoinepiau asmartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT zarasteinmeyer asmartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT yoanncharlon asmartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT laetitiacourbet asmartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT vincentrialle asmartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT benoitlepage asmartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT ericcampo asmartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT fatinourhashemi asmartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT antoinepiau smartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT zarasteinmeyer smartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT yoanncharlon smartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT laetitiacourbet smartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT vincentrialle smartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT benoitlepage smartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT ericcampo smartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy AT fatinourhashemi smartshoeinsoletomonitorfrailolderadultswalkingspeedresultsoftwoevaluationphasescompletedinalivinglabandthrougha12weekpilotstudy |